Radiation-Armed Robot Rapidly Destroys Human Lung Tumors

Super-intense radiation delivered by a robotic arm eradicated lung tumors in some human patients just 3-4 months after treatment, medical physicist Cihat Ozhasoglu, Ph.D. of the University of Pittsburgh Medical Center will report in early August at the 48th Annual Meeting of the American Association of Physicists in Medicine in Orlando. Although it is too early to determine the technique’s long-term effectiveness, Ozhasoglu and his colleagues find promise in this new approach to treat lung cancer and other tumors that move during breathing.

At the University of Pittsburgh, Ozhasoglu and approximately 30 colleagues form one of the largest US teams devoted to the CyberKnife, a radiation delivery system that uses an accurate, precise robotic arm to aim highly focused x-ray beams at the site of a tumor. Currently there are 76 active CyberKnife sites worldwide (with 45 in the US), and an additional 62 scheduled to be installed globally.

Recently, the Pittsburgh researchers upgraded their CyberKnife by adding a system called “Synchrony,” which accurately targets tumors that move as a result of breathing. Synchrony instructs the robotic arm to move the radiation source (a linear accelerator that produces x-rays) in sync with the tumor motion.

As a result of the unique real-time tumor tracking capabilities of their upgraded CyberKnife, the researchers have established detailed methods for the safe treatment of lung tumors which otherwise couldn’t be treated with a high dose of radiation due to lack of sufficient real-time tracking accuracy in other, more conventional radiation therapy machines.

Treating lung tumors with the enhanced Cyberknife requires only 1-3 sessions lasting 60-90 minutes. In conventional radiotherapy, patients must endure dozens of radiation treatments, each lasting about 15 minutes but requiring 20-30 hospital visits.

In a single treatment, Cyberknife blasts a lung tumor from all sides by delivering typically 100-150 intense, focused x-ray beams, causing the tumor to absorb approximately 10 times more radiation than in a conventional radiotherapy session. Cyberknife can deliver so much more radiation than other techniques because its robotic arm aims the x-rays precisely enough to avoid surrounding healthy tissue.

To track the moving tumor, the CyberKnife takes real-time x-ray pictures of the patient while using external markers attached to the patient’s chest or abdomen to follow tumors in real time with a few millimeters of accuracy. The researchers also applied Synchrony to treating tumors in the thorax and abdomen, which can move as much as 4 cm during respiration.

Meeting Paper: WE-D-VaIA-4, “Synchrony—Real-Time Respiratory Compensation system for the CyberKnife,” Wednesday, August 2, 2006, 2:20 PM, Room Valencia A.

Presented at: 48th Annual Meeting of the American Association of Physicists in Medicine, July 30-August 3, 2006, Orange County Convention Center, Orlando, FL.

American Institute of Physics (AIP)

RELATED STORIES:
Gene test helps predict lung cancer, study finds   Genetic mutation associated with increased risk of lung cancer   Tooth Loss Linked to Esophageal, Head and Neck, and Lung Cancer   Colour sensor breath test can detect lung cancer   Heavy marijuana use not linked to lung cancer   A new way to look at lung cancer and tobacco carcinogens   Psychiatric symptoms can be first sign of cancer   Eating Vegetables may significantly reduce your risk of lung cancer   Smac-ing lung cancer to death   PET imaging may improve lung cancer diagnosis   Infectious Agent May Impact Lung Cancer   Dietary Phytoestrogens Reduce Risk of Lung Cancer   Vitamins don’t reduce risk of lung cancer   New Approach Uses a Common Virus to Combat Deadly Lung Cancer   Wood smoke may raise lung cancer risk   Radiation ‘Highly Effective’ in Early Lung Cancer   New hope for ways to overcome drug resistance in lung cancer   Lung Cancer Cells Activate Inflammation to Induce Metastasis   Certain Vitamin Supplements May Increase Lung Cancer Risk, Especially in Smokers   New test predicts if lung cancer will spread   Genetic Mutation Associated With Increased Risk of Lung Cancer   Early Diagnosis of Lung Cancer: Where Do We Stand?

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]